Stem cell renewal and differentiation in acute myeloblasts leukaemia

Summary The defining properties of stem cells are capacities for self-renewal and, after determination, a limited number of terminal divisions. The blast cells of acute myeloblasts leukaemia (AML) are maintained by stem cells with these two properties. Since renewal and differentiation can be assessed separately in cultures of AML blasts, these cancer cells provide a useful model for examining stem regulation; such studies have practical importance for future developments in the treatment of AML. This paper considers three aspects of blast cell biology. First, evidence is presented that self-renewal and differentiation are regulated by specific genes; further, the DNA encoding these genes has structural features that affect the chemosensitivity of self-renewal. This sensitivity varies from patient-to-patient and is an important attribute contributing to variation in treatment efficacy. Second, the effects of myelopoietic growth factors on blast stem cells are presented and discussed, as these bear on the regulation of the balance between renewal and differentiation. Finally, models of leukaemic haemopoiesis are considered in light of the experimental findings. The suggestion is advanced that leukaemia can be explained better by abnormalities of gene expression than by blocked differentiation.

[1]  M. Minden,et al.  The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. , 1988, Leukemia.

[2]  M. Minden,et al.  The effects of recombinant CSF‐1 on the blast cells of acute myeloblastic leukemia in suspension culture , 1988, Journal of cellular physiology.

[3]  M. Minden,et al.  Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia. , 1988, Leukemia.

[4]  M. Minden,et al.  Expression of the CSF‐1 gene in the blast cells of acute myeloblastic leukemia: Association with reduced growth capacity , 1988, Journal of cellular physiology.

[5]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[6]  R. Arceci,et al.  Apparent role of the macrophage growth factor, CSF-1, in placental development , 1987, Nature.

[7]  J. Ihle,et al.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Tritchler,et al.  Response to 5-azacytidine of leukemic blast cells in suspension: a biological parameter associated with response to chemotherapy. , 1987, Leukemia.

[9]  S. Clark,et al.  B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Campana,et al.  Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. , 1987, Leukemia.

[11]  D. Rennick,et al.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  I. G. Young,et al.  Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Sachs,et al.  Control of hematopoietic cell growth regulators during mouse fetal development , 1987, Molecular and cellular biology.

[14]  M. Minden,et al.  The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. , 1987, Blood.

[15]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[16]  A. Larsen,et al.  Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Wagemaker,et al.  Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. , 1987, Blood.

[18]  C. J. Marshall.  Oncogenes and growth control 1987 , 1987, Cell.

[19]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[20]  M. Minden,et al.  High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributes. , 1987, Journal of Clinical Oncology.

[21]  E. McCulloch,et al.  Sensitivity to 5-azacytidine of blast progenitors in acute myeloblastic leukemia. , 1987, Blood.

[22]  P. Majerus,et al.  The metabolism of phosphoinositide-derived messenger molecules. , 1986, Science.

[23]  R. Evans,et al.  The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.

[24]  Yu-Chung Yang,et al.  Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3 , 1986, Cell.

[25]  M. Minden,et al.  Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia. , 1986, Blood.

[26]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[27]  D. Tritchler,et al.  The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. , 1986, Blood.

[28]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[29]  E. Brown,et al.  Molecular characterization and expression of the gene encoding human erythroid-potentiating activity , 1985, Nature.

[30]  E. Stanley,et al.  Purification of hemopoietin 1: a multilineage hemopoietic growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Tritchler,et al.  The effect of 5-azacytidine and its analogues on blast cell renewal in acute myeloblastic leukemia. , 1985, Blood.

[32]  S. Stass,et al.  The E rosette-associated antigen of T cells can be identified on blasts from patients with acute myeloblastic leukemia. , 1985, Blood.

[33]  E. McCulloch,et al.  Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[35]  L. Smith,et al.  Lineage infidelity in acute leukemia. , 1983, Blood.

[36]  Tatsutoshi Nakahata,et al.  A stochastic model of self‐renewal and commitment to differentiation of the primitive hemopoietic stem cells in culture , 1982, Journal of cellular physiology.

[37]  E. McCulloch,et al.  The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). , 1982, Blood.

[38]  E. McCulloch,et al.  Self-renewal capacity of leukemic blast progenitor cells. , 1981, Cancer research.

[39]  H. Preisler.  Prediction of response to chemotherapy in acute myelocytic leukemia. , 1980, Blood.

[40]  B. Hoogstraten,et al.  Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. , 1980, Blood.

[41]  G. Fioritoni,et al.  Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells. , 1980, Cancer research.

[42]  M. Minden,et al.  Acute myeloblastic leukemia considered as a clonal hemopathy. , 1979, Blood cells.

[43]  J. Till,et al.  COLONY ASSAY FOR PROLIFERATIVE BLAST CELLS CIRCULATING IN MYELOBLASTIC LEUKÆMIA , 1977, The Lancet.

[44]  E. Goldwasser.  Erythropoietin and the differentiation of red blood cells. , 1975, Federation proceedings.

[45]  J. Till,et al.  The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld. , 1965, Blood.

[46]  M. Minden,et al.  Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. , 1988, Blood.

[47]  J. Rowley,et al.  Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5. , 1987, Blood.

[48]  E. McCulloch,et al.  Adherent cells in cultures of blast progenitors in acute myeloblastic leukemia. , 1986, Leukemia research.

[49]  M. Greaves,et al.  Lineage promiscuity in hemopoietic differentiation and leukemia. , 1986, Blood.

[50]  G. Klaus,et al.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Neame,et al.  Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. , 1985, Blood.

[52]  E. McCulloch,et al.  2 – The Role of Stem Cells in Normal and Malignant Tissue , 1985 .

[53]  E. McCulloch,et al.  Hemopoietic stem cells: Their roles in human leukemia and certain continuous cell lines , 1984, Journal of cellular physiology. Supplement.

[54]  P. Fialkow.  Cell lineages in hematopoietic neoplasia studied with glucose‐6‐phosphate dehydrogenase cell markers , 1982, Journal of cellular physiology. Supplement.

[55]  E. McCulloch,et al.  The presence within single K-562 cells of erythropoietic and granulopoietic differentiation markers. , 1981, Blood.

[56]  E. McCulloch,et al.  EXPRESSION OF THE p 53 ONCOGENE IN ACUTE MYELOBLASTIC LEUKEMIA , 2022 .